
Monday, September 05, 2022 6:19:18 PM
Pivotal Upcoming Catalysts:
- Sep/Apr BioNTech Deal Consummation
- Sep/Oct EnACT Cohort 4 Top-line Results
- Oct IDWeek (Preclinical data mucormycosis strains)
- TBD Gilead meeting (LNC Remdesivir Phase 1?)
- Nov Q3 Conference Call
- Nov/Dec EnACT Cohort 4 Full Detailed Results
- Q4 BioNTech preclinical results
- Q4/Q1 MAT2203 Partner Announcement
- Q4/Q1 MAT2501 Phase 2 Plan
- Q4/Q1 Fully-funded!
- Q4/Q1 MAT2203 Phase 3 Commencement!
- Q4/Q1 Genentech Phase 1 trial(s)?
- Q4/Q1 LNC/mRNA Phase 1 trial(s)?
January 9-13, 2023 in Kampala, Uganda
The premier meeting on Crypto meningitis
11th International Cryptococcus and Cryptococcosis Conference (ICCC)

Liked By
Spread the love. Be the first to like this post!
Recent MTNB News
- Matinas BioPharma Reports 2022 Financial Results and Provides a Business Update • GlobeNewswire Inc. • 03/15/2023 08:05:00 PM
- Matinas BioPharma to Webcast Conference Call to Discuss 2022 Financial Results and Provide a Business Update on March 15, 2023 • GlobeNewswire Inc. • 03/08/2023 12:00:00 PM
- Matinas BioPharma Announces that MAT2203 Will Be Featured in Two Oral Presentations at ECCMID • GlobeNewswire Inc. • 03/02/2023 12:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/30/2023 09:01:51 PM
- Matinas BioPharma Provides Business Update and 2023 Strategic Outlook • GlobeNewswire Inc. • 01/30/2023 09:01:00 PM
- Matinas BioPharma to Provide Corporate Update and 2023 Business Outlook on January 30, 2023 • GlobeNewswire Inc. • 01/23/2023 12:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/12/2023 12:00:42 PM
- Matinas BioPharma Announces Collaboration with National Resilience to Explore and Evaluate Novel LNC Platform Delivery Technology for Certain Nucleic Acids • GlobeNewswire Inc. • 01/12/2023 12:00:00 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 12/22/2022 04:25:46 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 12/22/2022 04:24:31 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 12/22/2022 04:22:56 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 12/22/2022 04:20:32 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 12/22/2022 04:19:02 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/14/2022 10:44:02 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 11/02/2022 08:03:18 PM
- Matinas BioPharma Reports Third Quarter 2022 Financial Results and Highlights Recent Progress • GlobeNewswire Inc. • 11/02/2022 08:02:00 PM
- Matinas BioPharma to Webcast Conference Call Discussing Third Quarter 2022 Operational and Financial Results on November 2, 2022 • GlobeNewswire Inc. • 10/27/2022 11:00:00 AM
- Matinas BioPharma Announces Positive Interim Data from the Phase 2 EnACT Trial of MAT2203 for the Treatment of Cryptococcal Meningitis, Exceeding Primary Endpoint Threshold; Patient Survival in All-Oral Cohort 4 Regimen Currently 90% • GlobeNewswire Inc. • 10/21/2022 11:48:01 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 10/21/2022 11:02:06 AM
- Matinas BioPharma to Present at the ThinkEquity Annual Global Investment Conference • GlobeNewswire Inc. • 10/21/2022 11:00:00 AM
- Matinas BioPharma Announces Infectious Diseases Society of America (IDSA) has Selected the EnACT Phase 2 Trial Abstract of MAT2203 as its Outstanding Abstract and IDSA Awardee For IDWeek 2022 • GlobeNewswire Inc. • 10/19/2022 11:10:00 AM
- Matinas BioPharma to Present New MAT2203 (Oral Amphotericin B) Data During IDWeek 2022 • GlobeNewswire Inc. • 10/12/2022 11:00:00 AM
- Proxy Statement (definitive) (def 14a) • Edgar (US Regulatory) • 09/22/2022 09:02:26 PM
- Matinas BioPharma Announces Chairman Succession Plan • GlobeNewswire Inc. • 09/21/2022 11:00:00 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 09/13/2022 11:01:55 AM
Glucose Health, Inc. Fiscal 2022 Annual Report • GLUC • Mar 23, 2023 3:23 PM
Nextech3D.ai Announces Its AI-Powered SaaS Platform Toggle3D Experiences A +963% Jump in Users in 60-Days Crossing Over 1000 Users • NTAR • Mar 23, 2023 7:07 AM
Lifecycle Assessment by Benchmark Shows TMC's NORI-D Nodule Project Could Outperform Land-Based Routes of Producing Nickel, Copper and Cobalt in Almost Every Impact Category Analyzed • TMC • Mar 22, 2023 1:44 PM
Fineqia Announces Partnership with Paris Blockchain Week to Accelerate Digital Asset Innovation • FNQQF • Mar 22, 2023 10:03 AM
E-Cite and ClearMarket Launch Nationwide EV Distribution Network Becoming the First All EV Dealership Opening in the Cerritos Auto Square, the World's Largest Automall • VAPR • Mar 22, 2023 9:41 AM
Electromedical Announces $1.36M Net Proceeds from Building Sale to Fund WellnessPro Infinity ™ Launch and Convertible Note Retirement. • EMED • Mar 22, 2023 7:04 AM